Point Therapeutics Inc entered the industry of Commercial Biotechnical Research in 1996 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 541711, which describes it as a Commercial Biotechnical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Biotechnical Research. The business provides service to the B2B market.
To acquire more information, please contact Donald Kiepert by calling (617) 636-0680 during business hours. You can also write to the business’ Single Location at 75 Kneeland St Floor 10, Boston, Massachusetts MA 02111. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Point Therapeutics Inc |
| Representative: | Donald Kiepert |
| Place of Business: | 75 Kneeland St Floor 10, Boston, MA 02111 |
| Contact Number: | (617) 636-0680 |
| Type of Service: | Commercial Biotechnical Research |
| SIC Number: | 8731 |
| NAICS Number: | 541711 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 1996 |
| Income/Year: | $500.000 to $999.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Point Therapeutics Inc is a company operating from Suffolk, Massachusetts providing professional Commercial Biotechnical Research and relevant B2B variables. It was founded in 1996 and registered with the SIC code 8731 as Commercial Biotechnical Research, and with the NAICS code 541711 as Commercial Biotechnical Research.
With a current employee count of 1 to 4, Point Therapeutics Inc has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative Donald Kiepert at (617) 636-0680 for related queries, or to locate its Single Location using the coordinates .
The Single Location can also be found at the street address 75 Kneeland St Floor 10 in Boston, Massachusetts 02111 and can be engaged online through the company website at , the company Twitter , and Facebook page .